Lactoferrin Versus Ferrous Sulfate in Iron-deficiency During Pregnancy
Launched by AIN SHAMS UNIVERSITY · Nov 28, 2018
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women with single fetus.
- • Second trimester (14-20weeks of gestation).
- • Normal Hemoglobin level: more than10g\\dl.
- • Serum ferritin less than 15 mcg / L
- Exclusion Criteria:
- • Other type than iron-deficiency anemia (thalassemia, hemolytic anemia ... etc.)
- • Any other chronic diseases (bronchial asthma, renal or hepatic, hematological or cardiovascular diseases ... etc.)
- • Having hypersensitivity to iron preparations.
- • Treatment with any other iron preparation in the last month.
- • History of peptic ulcer, oesophagitis or hiatal hernia.
- • Medical disorders with pregnancy.
- • Need for alternative parenteral route to blood transfusion when rapid increase is required (perioperative anemia-severe anemia in late pregnancy-postpartum anemia) .
- • Bleeding in early pregnancy.
- • Refusal to participate in the study.
- • Family history of thalassemia-sickle cell anemia or malabsorption syndrome.
- • Recent blood transfusion.
- • Inflammatory bowel disease as intolerance of oral therapy but tolerated to parenteral route.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Abbaseya, Egypt
Patients applied
Trial Officials
Ghada Mohamed, MBBCh
Principal Investigator
G Darwish
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials